O-acetylated sialic acids: Multifaceted role in childhood acute lymphoblastic leukaemia

Biotechnology Journal

Volumn 4, Issue 3, 2009, Pages 361-374

  Chowdhury, Suchandra ^a   Mandal, Chitra ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

9 O acetylated sialic acids; Achatinin H; Childhood acute lymphoblastic leukaemia; Minimal residual disease

Indexed keywords

9-O-ACETYLATED SIALIC ACIDS; ACETYL DERIVATIVES; ACHATININ-H; CELL SURFACES; CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA; GLYCOLIPIDS; MINIMAL RESIDUAL DISEASE; OVER EXPRESSIONS; PATIENT POPULATIONS;

CARBOXYLIC ACIDS; CELL MEMBRANES; CHEMOTHERAPY; DIAGNOSIS; PATIENT TREATMENT; PEDIATRICS;

ACIDS;

SIALIC ACID DERIVATIVE; SIALOGLYCOPROTEIN; T LYMPHOCYTE RECEPTOR;

ACETYLATION; ACUTE LYMPHOBLASTIC LEUKEMIA; BINDING SITE; CHILDHOOD LEUKEMIA; CHROMOSOME ABERRATION; CYTOCHEMISTRY; CYTOGENETICS; DIAGNOSTIC VALUE; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHOBLAST; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ACETYLATION; CHILD; EPITOPES; FLOW CYTOMETRY; GENOTYPE; GLYCOLIPIDS; GLYCOPROTEINS; HUMANS; IMMUNOPHENOTYPING; NEOPLASM, RESIDUAL; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; SIALIC ACIDS; TUMOR MARKERS, BIOLOGICAL;

EID: 64549143473     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.200800253     Document Type: Review

References (57)

1. Champlin, R., Gale, R.P., Acute lymphoblastic leukemia: Recent advances in biology and therapy. Blood 1989, 73, 2051-2066.
2. Pui, C. H., Robison, L. L., Look, A. T., Acute lymphoblastic leukaemia. Lancet 2008, 371, 1030-1043.
3. Greaves, M. F., Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia. Cancer Res. 1981, 41, 4752-4766.
4. Greaves, M. F., Differentiation-linked leukemogenesis in lymphocytes. Science 1986, 234, 697-704.
5. Haferlach, T., Kern, W., Schnittger, S., Schoch, C., Modern diagnostics in acute leukemias. Crit.Rev. Oncol. Hematol. 2005, 56, 223-234.
6. Chan, K.W., Acute lymphoblastic leukemia. Curr. Probl. Pediatr. Adolesc. Health Care 2002, 32, 40-49.
7. Cortes, J. E., Kantarjian, H. M., Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy. Cancer 1995, 76, 2393-2417.
8. Kersey, J. H., Fifty years of studies of the biology and therapy of childhood leukemia. Blood 1997, 90, 4243-4251.
9. Civin, C. I., Trischmann, T. M., Fackler, M. J., Bemstein, I. D. et al., von dem Borne, A. E. G. Kr. (Eds.), Leucocyte Typing IV, Oxford University Press, Oxford, UK 1989, p. 818.
10. Pui, C. H., Hancock, M. L., Head, D. R., Rivera, G. K. et al., Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 1993, 82, 889-894.
11. Nadler, L. M., Korsmeyer, S. J., Anderson, K. C., Boyd, A.W. et al., B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B cell differentiation. J. Clin. Invest. 1984, 74, 332-340.
12. Kronenberg, M., Siu, G., Hood, L. E., Shastri, N., The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu. Rev. Immunol. 1986, 4, 529-591.
13. Sen, G., Mandal, C., The specificity of the binding site of AchatininH, a sialic acid-binding lectin from Achatina fulica. Carbohydr. Res. 1995, 268, 115-125.
14. Sinha, D., Mandal, C., Bhattacharya, D. K., Identification of 9-O acetyl sialoglycoconjugates (9-OAcSGs) as biomarkers in childhood acute lymphoblastic leukemia using a lectin, AchatininH, as a probe. Leukemia 1999, 13, 119-125.
15. Sinha, D., Mandal, C., Bhattacharya, D. K., A novel method for prognostic evaluation of childhood acute lymphoblastic leukemia. Leukemia 1999, 13, 309-312.
16. Sinha, D., Mandal, C., Bhattacharya, D. K., Development of a simple, blood based lymphoproliferation assay to assess the clinical status of patients with acute lymphoblastic leukemia. Leuk. Res. 1999, 23, 433-439.
17. Sinha, D., Bhattacharya, D. K., Mandal, C., A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukemia (ALL) employing achatininH: A 9-O-acetyl sialic acid binding lectin. Leuk. Res. 1999, 23, 803-809.
18. Mandal, C., Chatterjee, M., Sinha, D., Investigation of 9-Oacetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia. Br. J. Haematol. 2000, 110, 801-812.
19. Pal, S., Ghosh, S., Mandal, C., Kohla, G. et al., Purification and characterization of 9-O-acetylated sialoglycoproteins from leukemic cells and their potential as immunological tool for monitoring childhood acute lymphoblastic leukemia. Glycobiology 2004, 14, 859-870.
20. Pal, S., Ghosh, S., Bandyopadhyay, S., Mandal, C. et al., Differential expression of 9-O-acetylated sialoglycoconjugates on leukemic blasts: A potential tool for long-term monitoring of children with acute lymphoblastic leukemia. Int. J. Cancer 2004, 111, 270-277.
21. Ghosh, S., Bandyopadhyay, S., Mukherjee, K., Mallick, A. et al., O-acetylation of sialic acids is required for the survival of lymphoblasts in childhood acute lymphoblastic leukemia (ALL). Glycoconj. J. 2007, 24, 17-24.
22. Chowdhury, S., Bandyopadhyay, S., Chandra, S., Mandal, C., Comparative analysis of differential expression of sialic acids and adhesion molecules on mononuclear cells of bone marrow and peripheral blood in childhood acute lymphoblastic leukaemia at diagnosis and clinical remission. Indian J. Biochem. Biophys. 2007, 44, 357-365.
23. Chowdhury, S., Bandyopadhyay, S., Mandal, C., Chandra, S., Mandal, C., Flow-cytometric monitoring of disease-associated expression of 9-O-acetylated sialoglycoproteins in combination with known CD antigens, as an index for MRD in children with acute lymphoblastic leukaemia:A two-year longitudinal follow-up study. BMC Cancer 2008, 1, 8-40.
24. Sinha, D., Chatterjee, M. Mandal, C., O-acetylation of sialic acids- their detection, biological significance and alteration in diseases- a Review. Trends Glycosci. Glycotechnol. 2000, 12, 17-33.
25. Ghosh, S., Bandyopadhyay, S., Pal, S., Sinha, D. et al., 9-Oacetylated sialoglycoproteins:Novel molecules in childhood acute lymphoblastic leukaemia (ALL). Natl. Acad. Sci. Lett. 2006, 29, 17-23.
26. Hoelzer, D., Gokbuget, N., Ottmann, O., Pui, C. H. et al., Acute lymphoblastic leukemia. Hematology 2002, 162-192.
27. Campana, D., Determination of minimal residual disease in leukemia patients. Br. J. Haematol. 2003, 121, 823-838.
28. Szczepanéski, T., Flohr, T., van der Velden, V. H., Bartram, C. R., van Dongen, J. J., Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia. Best Pract. Res. Clin. Haematol. 2002, 15, 37-57.
29. Campana, D., Coustan-Smith, E., Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia. Best Pract. Res. Clin. Haematol. 2002, 15, 1-19.
30. van Dongen, J. J., Macintyre, E. A., Gabert, J. A., Delabesse, E. et al., Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia. Leukemia 1999, 13, 1901-1928.
31. Szczepański, T., Orfñao, A., van der Velden, V. H., San Miguel, J. F., van Dongen, J. J., Minimal residual disease in leukaemia patients. Lancet Oncol. 2001, 2, 409-417.
32. Mukherjee, K., Chava, A. K., Mandal, C., Dey, S. N. et al., Oacetylation of GD3 prevents its apoptotic effect and promotes survival of lymphoblasts in childhood acute lymphoblastic leukaemia. J. Cell Biochem. 2008, 105, 724-734.
33. Mandal, C., Mandal, C., Sialic acid binding lectins. Experientia 1990, 46, 433-441.
34. Varki, A., Multiple changes in sialic acid biology during human evolution. Glycoconj. J. 2008, DOI:101007/s10719-008-9183-z.
35. Rogers, G.N., Herrler, G., Paulson, J.C., Klenk, H.D., Influenza C virus uses 9-O-acetyl-N-acetyl neuraminic acid as a high affinity receptor determinant for attachment to cells. J. Biol. Chem. 1986, 261, 5947-5951.
36. Zimmer, G., Reuter, G., Schauer, R., Use of influenza C virus for detection of 9-O-acetylated sialic acids on immobilized glycoconjugates by esterase activity. Eur. J. Biochem. 1992, 204, 209-215.
37. Schauer, R., Achievements and challenges of sialic acid research. Glycoconj. J. 2000, 17, 485-499.
38. Chava, A. K., Chatterjee, M., Sharma, V., Sundar, S., Mandal, C., Variable degree of alternative complement pathway-mediated hemolysis in Indian visceral leishmaniasis induced by differential expression of 9-O-acetylated sialoglycans. J. Infect. Dis. 2004, 189, 1257-1264.
39. Chatterjee, M., Sharma, V., Mandal, C., Sundar, S., Sen, S., Identification of antibodies directed against O-acetylated sialic acids in visceral leishmaniasis: Its diagnostic and prognostic role. Glycoconj. J. 1998, 15, 1141-1147.
40. Bandyopadhyay, S., Chatterjee, M., Sundar, S., Mandal, C., Identification of 9-O-acetylated sialoglycans on peripheral blood mononuclear cells in Indian Visceral Leishmaniasis. Glycoconj. J. 2004, 20, 531-536.
41. Basu, S., Mandal, C., Allen, A. K., Chemical-modification studies of a unique sialic acid-binding lectin from the snail Achatina fulica. Involvement of tryptophan and histidine residues in biological activity. Biochem. J. 1988, 254, 195-202.
42. Mandal, C., Basu, S., Mandal, C., Physiochemical studies on achatininH, a novel sialic acid-binding lectin. Biochem. J. 1989, 257, 65-71.
43. Sen, G., Mandal, C., Chowdhury, M., Albumen gland of the snail Achatina fulica is the site for synthesis of AchatininH, a sialic acid binding lectin. Mol. Cell Biochem. 1992, 117, 133-138.
44. Biswas, C., Mandal, C., The role of amoebocytes in endotoxin-mediated coagulation in the innate immunity of Achatina fulica snails. Scand. J. Immunol. 1999, 49, 131-138.
45. Biswas, C., Sinha, D., Mandal, C., Investigation on interaction of Achatinin, a 9-O-acetyl sialic acid-binding lectin, with lipopolysaccharide in the innate immunity of Achatina fulica snails. Mol. Immunol. 2000, 37, 745-754.
46. Shukla, A. K., Schauer R., Fluorometric determination of unsubstituted and 9(8)-O-acetylated sialic acids in erythrocyte membranes. Hoppe-Seylers Z. Physiol. Chem. 1982, 363, 255-262.
47. Pal, S., Chatterjee, M., Bhattacharya, D. K., Bandhyopadhyay, S., Mandal, C., Identification and purification of cytolytic antibodies directed against O-acetylated sialic acid in childhood acute lymphoblastic leukemia. Glycobiology 2000, 10, 539-549.
48. Pal, S., Chatterjee, M., Bhattacharya, D. K., Bandhyopadhyay, S. et al., O-acetyl sialic acid specific IgM in childhood acute lymphoblastic leukaemia. Glycoconj. J. 2001, 18, 529-537.
49. Bandyopadhyay, S., Chatterjee, M., Banavali, S. D., Pal, S. et al., Antibodies against 9-O-acetylated sialic acids in childhood acute lymphoblastic leukemia: A two-year study with 186 samples following protocol MCP 943. Indian J. Biochem. Biophys. 2006, 43, 7-14.
50. Pal, S., Bandyopadhyay, S., Chatterjee, M., Bhattacharya, D. K. et al., Antibodies against 9-O-acetylated sialoglycans: A potent marker to monitor clinical status in childhood acute lymphoblastic leukemia. Clin. Biochem. 2004, 37, 395-403.
51. Bandyopadhyay, S., Mukherjee, K., Chatterjee, M., Bhattacharya, D. K., Mandal, C., Detection of immune-complexed 9-O-acetylated sialoglycoconjugates in the sera of patients with pediatric acute lymphoblastic leukemia. J. Immunol. Methods 2005, 297, 13-26.
52. Mandal, C., Sinha, D., Sharma, V., Bhattacharya, D. K., O-acetyl sialic acid binding lectin as a probe for detection of subtle change on cell surface induced during acute lymphoblastic leukemia (ALL) and its clinical application. Indian J. Biochem. Biophys. 1997, 34, 82-86.
53. Ghosh, S., Bandyopadhyay, S., Pal, S., Das, B. et al., Increased interferon gamma production by peripheral blood mononuclear cells in response to stimulation of overexpressed disease-specific 9-O-acetylated sialoglycoconjugates in children suffering from acute lymphoblastic leukaemia. Br. J. Haematol. 2005, 128, 35-41.
54. Ghosh, S., Bandyopadhyay, S., Mallick, A., Pal, S. et al., Interferon gamma promotes survival of lymphoblasts overexpressing 9-O-acetylated sialoglycoconjugates in childhood acute lymphoblastic leukaemia (ALL). J. Cell. Biochem. 2005, 95, 206-216.
55. Bandyopadhyay, S., Bhattacharyya, A., Mallick, A., Sen, A. K. et al., Over-expressed IgG2 antibodies against O-acetylated sialoglycoconjugates incapable of proper effector functioning in childhood acute lymphoblastic leukemia. Int. Immunol. 2005, 17, 177-191.
56. Ghosh, S., Bandyopadhyay, S., Bhattacharya, D. K., Mandal, C., Altered erythrocyte membrane characteristics during anemia in childhood acute lymphoblastic leukemia. Ann. Hematol. 2005, 84, 76-84.
57. Mandal, C., Srinivasan, G. V., Chowdhury, S., Chandra, S. et al., High level of sialate-O-acetyltransferase activity in lymphoblasts of childhood acute lymphoblastic leukaemia (ALL): Enzyme characterization and correlation with disease status. Glycoconj. J. 2008, 26, 57-73.